Alexion Pharmaceuticals, Inc. (ALXN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN)

ALXN 182.50

0.0%

Jul 28 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (750)	3/20/2007 2:54:10 PM
From: Ian@SI	Read Replies (1) of 824

Jim, Regardless of a $100k or $300K annual price, they'll be perceived as gouging needy pts. And the whole generic drug industry is based upon the public's desire to avoid being gouged by big pharma on far more "reasonably" priced drugs. Without having sufficient facts to do the real math, I suspect that big pharma is "gouging" far more on arthritis treatments than ALXN will ever do for PNH. And if ALXN truly misbehaves, it does risk the wrath of some gov't in some part of the world taking action to permit a generic supply to come into being sooner than would otherwise be the case. IMO, Ian

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next